Streetbeat News

Stock Prices

CMCSA

MCD

META

NFLX

NWSA

TRI

Meta Platforms Inc (NASDAQ:META) launched Threads, a platform similar to Twitter, which is gaining attention and followers. A study by WebsitePlanet found that despite its recent launch, Threads is outpacing Twitter in terms of likes and engagement. Brands like Red Bull and Netflix Inc (NASDAQ:NFLX) are seeing higher engagement on Threads than on Twitter. However, Twitter still has a larger user base due to its 15-year tenure.

Portfolio Pulse from AJ Fabino

July 07, 2023 | 4:53 pm

IFF

International Flavors & Fragrances, Inc.'s (NYSE:IFF) unit Danisco Animal Nutrition & Health has announced that its phytase enzyme, Axtra PHY GOLD, has been authorized for in-feed use in the EU. The enzyme does not interfere with digestion and animal performance and works faster than any other competitor's phytase to break down phytate present in grains. It is available globally in markets including the U.S., Latin America, Asia Pacific, and most recently in the EU. IFF shares are trading higher by 2.02% to $79.61.

Portfolio Pulse from Nabaparna Bhattacharya

July 07, 2023 | 4:51 pm

MRK

A significant amount of unusual options activity has been observed for Merck & Co (NYSE:MRK), with a majority of investors taking a bullish stance. Of the 11 strange trades detected, 63% were bullish and 36% were bearish. The total amount for puts was $255,245 and for calls was $234,890. Whales have been targeting a price range from $92.5 to $120.0 for Merck & Co over the last 3 months. The current price of MRK is down -2.36% at $109.11.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 4:49 pm

REGN

Unusual options activity has been observed for Regeneron Pharmaceuticals (NASDAQ:REGN), with a large position indicating a bullish stance. The sentiment among these big-money traders is split between 60% bullish and 40% bearish. The whales have been targeting a price range from $600.0 to $780.0 for Regeneron Pharmaceuticals over the last 3 months. The current price of REGN is down -1.31% at $695.57. Several experts have maintained their ratings on Regeneron Pharmaceuticals, with price targets ranging from $789 to $1045.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 4:49 pm

BX

Viral Patel, Blackstone Credit's global head of technology investing, sees private credit as an attractive option for tech firms amidst a sluggish IPO market. Patel disclosed Blackstone's focus on cash flow-based loans and the shift from ARR loans to EBITDA-based loans for companies reducing top-line growth. He also expressed a positive outlook on IPOs and a preference for cybersecurity and software companies catering to corporations' increasing data volume.

Portfolio Pulse from Anusuya Lahiri

July 07, 2023 | 4:44 pm

CLSK

CleanSpark, Inc. (NASDAQ:CLSK) shares are trading higher on Friday, continuing the stock's upward momentum from recent sessions. This follows the company's announcement of a 170% quarter-over-quarter increase in its Bitcoin holdings. Shares of CLSK are up more than 40% over the past five trading sessions and up more than 145% higher over the last three months.

Portfolio Pulse from Erica Kollmann

July 07, 2023 | 4:43 pm

PLTR

Shares of Palantir Technologies Inc (NYSE:PLTR) are trading higher by 4.0% to $15.74 during Friday's session, rebounding from Thursday's weakness. The rise is attributed to better-than-expected U.S. jobs data and the likelihood of more rate hikes as stated by Dallas Fed president Logan. The company's shares have also surged by 145% on a year-to-date basis amid strength in AI-related stocks.

Portfolio Pulse from Henry Khederian

July 07, 2023 | 4:43 pm

NVDA

Tigress Financial Partners analyst Ivan Feinseth reiterated a Buy rating on Nvidia Corp (NASDAQ:NVDA) and raised the price target from $320 to $560. Nvidia is emerging as a core holding in the generative AI investment theme and is expected to benefit from the projected $1 trillion worth of global data infrastructure spending transitioning to accelerated computing. The company's Q1 results showed strong revenue growth, with the Data Center segment achieving record revenue of $4.28 billion, up 14% YoY. Nvidia's forecasted growth includes a 107.43% increase in net sales revenue to $53.68 billion and a 131.19% increase in economic operating cash flow to $33.15 billion over the next twelve months.

Portfolio Pulse from Anusuya Lahiri

July 07, 2023 | 4:42 pm

LEVI

Levi Strauss & Co. (NYSE:LEVI) shares are trading lower after the company reported a Q2 margin decline and issued soft 2023 EPS guidance. The company reported a 9% decrease in net revenues, with wholesale net revenues decreasing by 22%. Adjusted diluted EPS is now projected between $1.10 to $1.20, down from $1.30 to $1.40. The stock is moving lower on high volume, with over 8.8 million shares traded compared to the 100-day average of 2.5 million shares.

Portfolio Pulse from Erica Kollmann

July 07, 2023 | 4:35 pm

VZ

A significant bearish stance has been taken on Verizon Communications (NYSE:VZ) as indicated by unusual options activity. The overall sentiment of these big-money traders is split between 38% bullish and 61% bearish. The whales have been targeting a price range from $25.0 to $60.0 for Verizon Communications over the last 3 months. The price of VZ is down -0.58% at $36.27.

Portfolio Pulse from Benzinga Insights

July 07, 2023 | 4:33 pm